Clinical trial Recruiting at 1 site Phase 1 Interventional Ages 60 and up

Personalized cognitive training program for mild cognitive impairment

Official title: Personalized Engine for Speed of Information Processing

Run by Stanford University · NCT06005038 · Data updated 2026-11-12

This study is trying out a personalized computer game designed to help people with mild cognitive impairment improve their thinking skills by adjusting the difficulty based on their heart rate and performance.

Quick facts

PhasePhase 1
Study typeInterventional
Ages60 Years and up
SexAll
Enrollment50 (estimated)
SponsorStanford University
Academic / other
Locations1 site (Palo Alto, California)
StatusRecruiting
StartedJanuary 12, 2024
Main results expectedDecember 1, 2026
Study endsDecember 31, 2026
Registry record updatedMay 17, 2024
Trial IDNCT06005038 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 60 and older who exhibit mild cognitive impairment and can understand and participate in the training program.

Probably not a fit

Patients currently enrolled in other cognitive improvement studies or those with uncontrollable major depression may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to develop and pilot test a personalized computer-based cognitive training program designed for individuals with mild cognitive impairment. The program adjusts the difficulty of training tasks based on participants' biofeedback, such as heart rate, and cognitive performance to optimize their training experience. Participants will be randomly assigned to one of two groups, each engaging in different versions of a computerized training game while their ECG is monitored to maintain blinding. The goal is to assess the effectiveness of this tailored approach in improving cognitive function.

Why it matters

Potential benefit: If successful, this intervention could enhance cognitive function in patients with mild cognitive impairment, potentially delaying the progression to more severe cognitive decline.

How similar studies have gone: Other studies have shown promise in using personalized cognitive training approaches, suggesting potential for success in this novel application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. criteria related to defining "mild cognitive impairment": a. Presence of memory complaint; b. Rey Auditory Verbal Learning Test delayed recall (for memory) \< 59% of age-adjusted norm; c. Montreal Cognitive Assessment (for global cognition) ranged 18 and 27; d. Functional Assessment Questionnaire (for activities of daily living) \< 20.
2. intact score for San Diego Brief Assessment of Capacity to Consent (UBACC).
3. if a participant is on AD medication (i.e., memantine, cholinesterase inhibitors, amyloid antibodies), antidepressants, anxiolytics, or vascular risk or diseases related medications (e.g., beta-blocker), the dose should be stable for 3 months prior to recruitment.
4. age 60+,
5. read and understand English
6. adequate visual and hearing acuity for testing by self-report,
7. community-dwelling (including independent living).

Exclusion Criteria:

1. current enrollment in another cognitive improvement study;
2. uncontrollable major depression;
3. major cerebrovascular and cardiovascular diseases (e.g., congestive heart failure, pacemaker, prior myocardial infarction);
4. having an active legal guardian (indicating impaired capacity for decision making);
5. currently pregnant
6. 3T MRI contraindication
7. Neurological conditions: Neurodegenerative disease diagnosis such as Parkinson's, Alzheimers, dementia, multiple sclerosis. Of note, other neurological conditions/injury such as stroke, seizures, traumatic brain injury, will be evaluated for inclusion/exclusion on a case-by-case basis based on event recency, severity, and recovery.

Where it's running

  • CogT Lab, Stanford University
    Palo Alto, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.